01Research
Urothelial carcinoma
Combining gene expression, molecular features, and clinical data to study anti-PD-1 treatment outcomes.
SITC 2022 · Exploratory studyView research
Research portfolio
Explore the data, methods, and limitations behind Alghorismus’s work in treatment-response modeling.
Combining gene expression, molecular features, and clinical data to study anti-PD-1 treatment outcomes.
Investigating circulating CD8+ T-cell transcriptomics as a potential source of response information.
Evaluating multimodal models of pathological complete response using I-SPY2 trial data.
Start a scientific conversation
Tell us about your research objective, available data, and the decision your study needs to inform.
Discuss a project